Opioid prescribing for acute postoperative pain after cutaneous surgery

Jonathan J. Lopez, Nafisseh S. Warner, Christopher J. Arpey, Christian Baum, Jerry D. Brewer, Clark C. Otley, Halena M. Gazelka, Randall K. Roenigk

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Little information is available to predict which patients require opioid analgesia following cutaneous surgery. When opioids are indicated, information regarding the optimal opioid agent selection and dosage is lacking. Objective: To make recommendations for opioid prescription after cutaneous surgery. Methods: A PubMed literature search was conducted to review the available literature. Recommendations are presented on the basis of available evidence and the opinion of the authors. Results: Most patients undergoing cutaneous surgery do not require opioid analgesia. For those who do, the duration of pain warranting opioid analgesia is generally less than 36 hours. Opioid refill requests warrant a follow-up visit to ascertain the cause of ongoing pain after excisional procedures. Limitations: The recommendations are not based on prospective randomized trials. Conclusions: The presented recommendations for opioid prescription practice are derived from available evidence, recommendations, and expert opinion.

Original languageEnglish (US)
Pages (from-to)743-748
Number of pages6
JournalJournal of the American Academy of Dermatology
Volume80
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Dermatologic Surgical Procedures
Acute Pain
Postoperative Pain
Opioid Analgesics
Analgesia
Prescriptions
Pain
Expert Testimony
PubMed

Keywords

  • addiction
  • cutaneous surgery
  • dermatologic surgery
  • flap
  • Mohs micrographic surgery
  • narcotic
  • opioid
  • pain
  • public health

ASJC Scopus subject areas

  • Dermatology

Cite this

Lopez, J. J., Warner, N. S., Arpey, C. J., Baum, C., Brewer, J. D., Otley, C. C., ... Roenigk, R. K. (2019). Opioid prescribing for acute postoperative pain after cutaneous surgery. Journal of the American Academy of Dermatology, 80(3), 743-748. https://doi.org/10.1016/j.jaad.2018.09.032

Opioid prescribing for acute postoperative pain after cutaneous surgery. / Lopez, Jonathan J.; Warner, Nafisseh S.; Arpey, Christopher J.; Baum, Christian; Brewer, Jerry D.; Otley, Clark C.; Gazelka, Halena M.; Roenigk, Randall K.

In: Journal of the American Academy of Dermatology, Vol. 80, No. 3, 01.03.2019, p. 743-748.

Research output: Contribution to journalArticle

Lopez, JJ, Warner, NS, Arpey, CJ, Baum, C, Brewer, JD, Otley, CC, Gazelka, HM & Roenigk, RK 2019, 'Opioid prescribing for acute postoperative pain after cutaneous surgery', Journal of the American Academy of Dermatology, vol. 80, no. 3, pp. 743-748. https://doi.org/10.1016/j.jaad.2018.09.032
Lopez, Jonathan J. ; Warner, Nafisseh S. ; Arpey, Christopher J. ; Baum, Christian ; Brewer, Jerry D. ; Otley, Clark C. ; Gazelka, Halena M. ; Roenigk, Randall K. / Opioid prescribing for acute postoperative pain after cutaneous surgery. In: Journal of the American Academy of Dermatology. 2019 ; Vol. 80, No. 3. pp. 743-748.
@article{f4815267280646eda5e273f223a38f97,
title = "Opioid prescribing for acute postoperative pain after cutaneous surgery",
abstract = "Background: Little information is available to predict which patients require opioid analgesia following cutaneous surgery. When opioids are indicated, information regarding the optimal opioid agent selection and dosage is lacking. Objective: To make recommendations for opioid prescription after cutaneous surgery. Methods: A PubMed literature search was conducted to review the available literature. Recommendations are presented on the basis of available evidence and the opinion of the authors. Results: Most patients undergoing cutaneous surgery do not require opioid analgesia. For those who do, the duration of pain warranting opioid analgesia is generally less than 36 hours. Opioid refill requests warrant a follow-up visit to ascertain the cause of ongoing pain after excisional procedures. Limitations: The recommendations are not based on prospective randomized trials. Conclusions: The presented recommendations for opioid prescription practice are derived from available evidence, recommendations, and expert opinion.",
keywords = "addiction, cutaneous surgery, dermatologic surgery, flap, Mohs micrographic surgery, narcotic, opioid, pain, public health",
author = "Lopez, {Jonathan J.} and Warner, {Nafisseh S.} and Arpey, {Christopher J.} and Christian Baum and Brewer, {Jerry D.} and Otley, {Clark C.} and Gazelka, {Halena M.} and Roenigk, {Randall K.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jaad.2018.09.032",
language = "English (US)",
volume = "80",
pages = "743--748",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Opioid prescribing for acute postoperative pain after cutaneous surgery

AU - Lopez, Jonathan J.

AU - Warner, Nafisseh S.

AU - Arpey, Christopher J.

AU - Baum, Christian

AU - Brewer, Jerry D.

AU - Otley, Clark C.

AU - Gazelka, Halena M.

AU - Roenigk, Randall K.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background: Little information is available to predict which patients require opioid analgesia following cutaneous surgery. When opioids are indicated, information regarding the optimal opioid agent selection and dosage is lacking. Objective: To make recommendations for opioid prescription after cutaneous surgery. Methods: A PubMed literature search was conducted to review the available literature. Recommendations are presented on the basis of available evidence and the opinion of the authors. Results: Most patients undergoing cutaneous surgery do not require opioid analgesia. For those who do, the duration of pain warranting opioid analgesia is generally less than 36 hours. Opioid refill requests warrant a follow-up visit to ascertain the cause of ongoing pain after excisional procedures. Limitations: The recommendations are not based on prospective randomized trials. Conclusions: The presented recommendations for opioid prescription practice are derived from available evidence, recommendations, and expert opinion.

AB - Background: Little information is available to predict which patients require opioid analgesia following cutaneous surgery. When opioids are indicated, information regarding the optimal opioid agent selection and dosage is lacking. Objective: To make recommendations for opioid prescription after cutaneous surgery. Methods: A PubMed literature search was conducted to review the available literature. Recommendations are presented on the basis of available evidence and the opinion of the authors. Results: Most patients undergoing cutaneous surgery do not require opioid analgesia. For those who do, the duration of pain warranting opioid analgesia is generally less than 36 hours. Opioid refill requests warrant a follow-up visit to ascertain the cause of ongoing pain after excisional procedures. Limitations: The recommendations are not based on prospective randomized trials. Conclusions: The presented recommendations for opioid prescription practice are derived from available evidence, recommendations, and expert opinion.

KW - addiction

KW - cutaneous surgery

KW - dermatologic surgery

KW - flap

KW - Mohs micrographic surgery

KW - narcotic

KW - opioid

KW - pain

KW - public health

UR - http://www.scopus.com/inward/record.url?scp=85061192947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061192947&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.09.032

DO - 10.1016/j.jaad.2018.09.032

M3 - Article

C2 - 30287315

AN - SCOPUS:85061192947

VL - 80

SP - 743

EP - 748

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -